Literature DB >> 21352951

Polymorphism in the DNA repair enzyme XRCC1: utility of current database and implications for human health risk assessment.

Gary Ginsberg1, Kenneth Angle, Kathryn Guyton, Babasaheb Sonawane.   

Abstract

Genetic polymorphisms are increasingly recognized as sources of variability not only in toxicokinetic but also in toxicodynamic response to environmental agents. XRCC1 is involved in base excision repair (BER) of DNA; it has variant genotypes that are associated with modified repair function. This analysis focuses on four polymorphisms: three in the coding region that affect protein structure and one in an upstream regulatory sequence that affects gene expression. The Arg399Gln variant is the most widely studied with evidence supporting a quantitative effect of genotype on phenotype. The homozygous variant (Gln/Gln) can have 3-4-fold diminished capacity to remove DNA adducts and oxidized DNA damage. This variant is relatively common in Caucasians and Asians where approximately 10% are homozygous variant. In contrast, the Arg194Trp variant appears to protect against genotoxic effects although the degree to which DNA repair is enhanced by this polymorphism is uncertain. The homozygous variant is rare in Caucasians and African Americans but it is present at 7% in Asians. A third coding region polymorphism at codon 280 appears to decrease repair function but additional quantitative information is needed and the homozygous variant is rare across populations studied. A polymorphism in an upstream promoter binding sequence (-77T>C) appears to lower XRCC1 levels by decreasing gene expression. Based upon genotype effect on phenotype and allele frequency, the current analysis finds that the codon 399 and upstream (-77) polymorphisms have the greatest potential to affect the toxicodynamic response to DNA damaging agents. However, the implications for risk assessment are limited by the likelihood that polymorphisms in multiple BER genes interact to modulate DNA repair.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352951     DOI: 10.1016/j.mrrev.2011.02.001

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  32 in total

1.  Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.

Authors:  Yi Li; Yi Huang; Yu-Shu Cao; Jia Zeng; Wan-Ning Tong; Shi-Lin Xu; An-Shan Zhuo
Journal:  Tumour Biol       Date:  2013-07-25

2.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

3.  Inter-individual variability in the response of human peripheral blood lymphocytes to ionizing radiation: comparison of the dicentric and micronucleus assays.

Authors:  Jelena Pajic; Boban Rakic; Branislav Rovcanin; Dubravka Jovicic; Ivana Novakovic; Aleksandar Milovanovic; Vesna Pajic
Journal:  Radiat Environ Biophys       Date:  2015-04-24       Impact factor: 1.925

4.  X-ray repair cross-complementing group 1 Arg194Trp polymorphism is associated with increased risk of lung cancer in Chinese Han population.

Authors:  Tao Wu; Yun-hua Xu; Xiao-lei Ye
Journal:  Tumour Biol       Date:  2013-05-08

5.  Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.

Authors:  Honglei Jiang; Dan Wu; Dongyan Ma; Guofu Lin; Jian Liang; Junzhe Jin
Journal:  Tumour Biol       Date:  2013-06-27

Review 6.  Genome instability in Alzheimer disease.

Authors:  Yujun Hou; Hyundong Song; Deborah L Croteau; Mansour Akbari; Vilhelm A Bohr
Journal:  Mech Ageing Dev       Date:  2016-04-20       Impact factor: 5.432

Review 7.  Polymorphisms in human DNA repair genes and head and neck squamous cell carcinoma.

Authors:  Rim Khlifi; Ahmed Rebai; Amel Hamza-Chaffai
Journal:  J Genet       Date:  2012       Impact factor: 1.166

8.  A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.

Authors:  Xiangtai Wei; Duo Chen; Tao Lv
Journal:  Mol Biol Rep       Date:  2012-10-25       Impact factor: 2.316

9.  Associations between three XRCC1 polymorphisms and glioma risk: a meta-analysis.

Authors:  Haijun Zhang; Hang Liu; Jennifer L Knauss
Journal:  Tumour Biol       Date:  2013-05-29

10.  XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.

Authors:  Yi Zhang; Yin Wang; Jian Wu; Long-Jiang Li
Journal:  Tumour Biol       Date:  2013-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.